COVID-19 Vaccine: You Can Thank HIV and Ebola Vaccine Researchers
Most of all, thank the protesters who demanded research into HIV.
“A new HIV vaccine, based on the Moderna COVID-19 inoculation, has shown a 97% antibody response rate in Phase I clinical trials.”
Wait, what? How the heck is this not front-and-center on the TV network news? The moment…